Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer

Overview of attention for article published in New England Journal of Medicine, September 2024

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

news: 30 news outlets
blogs: 3 blogs
twitter: 169 X users
video: 1 YouTube creator

guideline: 4 clinical guideline sources
bluesky: 2 Bluesky users
podcasts: 4 podcasts

Readers on

mendeley: 228 Mendeley

So far, Altmetric has seen 5 Guidelines that reference this research output.

Optimal Management of Muscle-invasive Bladder Cancer: Recommendations from the International Bladder Cancer Group

Clinical guideline published by International Bladder Cancer Group (IBCG) on 21 Feb 2026

The International Bladder Cancer Group (IBCG) is a global consortium dedicated to enhancing bladder cancer care through evidence-based guidelines and educational initiatives. By uniting experts, IBCG aims to improve patient outcomes and establish international standards in treatment.

Kidney transplantation from donors with cancer or history of cancer: Transplantation and cancerology committee of Association Française d’Urologie guidelines (CTAFU/CCAFU)

Clinical guideline published by Association française d’urologie (AFU) on 01 Nov 2025

The Association Française d’Urologie aims to promote urological science, the development of global policies for the quality and safety of care, and the improvement of practices.

French recommendations of the AFU Oncology Committee for Bladder Cancer: Update 2025

Clinical guideline published by Association française d’urologie (AFU) on 17 Oct 2025

The Association Française d’Urologie aims to promote urological science, the development of global policies for the quality and safety of care, and the improvement of practices.

SEOM–SOGUG clinical guideline for urothelial cancer (2025)

Clinical guideline published by Sociedad Española de Oncología Médica (SEOM) on 17 Sep 2025

The Sociedad Española de Oncología Médica (SEOM) is a leading organization in Spain dedicated to oncology. It provides comprehensive resources, including clinical guidelines, educational programs, and research support, aimed at improving cancer care and treatment outcomes for patients.

This page shows the most recent posts that mention this research output. Click here to find out how to access more activity, including 1 additional posts.